The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
Title |
Biodegradable Nanoparticles Mediated Co-delivery of Erlotinib (ELTN) and Fedratinib (FDTN) Toward the Treatment of ELTN-Resistant Non-small Cell Lung Cancer (NSCLC) via Suppression of the JAK2/STAT3 Signaling Pathway
|
---|---|
Published in |
Frontiers in Pharmacology, November 2018
|
DOI | 10.3389/fphar.2018.01214 |
Pubmed ID | |
Authors |
Donglai Chen, Fuquan Zhang, Jinhui Wang, Hua He, Shanzhou Duan, Rongying Zhu, Chang Chen, Lichen Yin, Yongbing Chen |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 30 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 30 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 4 | 13% |
Student > Bachelor | 3 | 10% |
Researcher | 3 | 10% |
Student > Master | 3 | 10% |
Other | 2 | 7% |
Other | 3 | 10% |
Unknown | 12 | 40% |
Readers by discipline | Count | As % |
---|---|---|
Pharmacology, Toxicology and Pharmaceutical Science | 6 | 20% |
Biochemistry, Genetics and Molecular Biology | 3 | 10% |
Unspecified | 2 | 7% |
Medicine and Dentistry | 2 | 7% |
Chemical Engineering | 1 | 3% |
Other | 4 | 13% |
Unknown | 12 | 40% |
Attention Score in Context
This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 December 2018.
All research outputs
#18,652,089
of 23,106,934 outputs
Outputs from Frontiers in Pharmacology
#8,448
of 16,459 outputs
Outputs of similar age
#263,407
of 343,825 outputs
Outputs of similar age from Frontiers in Pharmacology
#230
of 393 outputs
Altmetric has tracked 23,106,934 research outputs across all sources so far. This one is in the 11th percentile – i.e., 11% of other outputs scored the same or lower than it.
So far Altmetric has tracked 16,459 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.0. This one is in the 37th percentile – i.e., 37% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 343,825 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 12th percentile – i.e., 12% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 393 others from the same source and published within six weeks on either side of this one. This one is in the 27th percentile – i.e., 27% of its contemporaries scored the same or lower than it.